Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
暂无分享,去创建一个
Qinying Zhao | M. Bednar | A. Burstein | S. Styren | C. Alvey | J. Landen | F. McCush | J. Kupiec | J. Ross | Wendy W. Ma